Harvard Apparatus Regenerative Technology, Inc. financial data

Symbol
HRGN on OTC
Location
Holliston, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 192 % +105%
Quick Ratio 4.09 % -1.21%
Debt-to-equity 65.3 %
Return On Equity -344 % +43.7%
Return On Assets -208 % -6.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.2M shares +7.85%
Common Stock, Shares, Outstanding 17.2M shares +7.85%
Entity Public Float 28.3M USD -16.3%
Common Stock, Value, Issued 172K USD +8.18%
Weighted Average Number of Shares Outstanding, Basic 17M shares +13.4%
Weighted Average Number of Shares Outstanding, Diluted 15M shares +8.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 743K USD +108%
Cost of Revenue 622K USD +60%
Research and Development Expense 2.22M USD -17.2%
Selling and Marketing Expense 449K USD -91.3%
General and Administrative Expense 4.35M USD -14.5%
Costs and Expenses 7.33M USD -4.22%
Operating Income (Loss) -6.58M USD +19.6%
Nonoperating Income (Expense) 56K USD
Net Income (Loss) Attributable to Parent -6.53M USD +20.6%
Earnings Per Share, Basic 0 USD/shares +33.3%
Earnings Per Share, Diluted 0 USD/shares +16.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.32M USD -63.3%
Cash, Cash Equivalents, and Short-term Investments 3.6M USD +140%
Accounts Receivable, after Allowance for Credit Loss, Current 3K USD +200%
Inventory, Net 22K USD -80.5%
Assets, Current 1.63M USD -59.1%
Property, Plant and Equipment, Net 7K USD -46.2%
Operating Lease, Right-of-Use Asset 221K USD -30.5%
Other Assets, Noncurrent 62K USD -64.2%
Assets 2.55M USD -52.1%
Accounts Payable, Current 313K USD -38.3%
Employee-related Liabilities, Current 116K USD +5.46%
Contract with Customer, Liability, Current 128K USD
Liabilities, Current 876K USD -29.8%
Operating Lease, Liability, Noncurrent 116K USD -48.2%
Liabilities 992K USD -32.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -9K USD +62.5%
Retained Earnings (Accumulated Deficit) -105M USD -6.64%
Stockholders' Equity Attributable to Parent 1.55M USD -59.5%
Liabilities and Equity 2.55M USD -52.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -758K USD +21%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -9K USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 17.2M shares +7.85%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -758K USD -374%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 432K USD -65.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD -77.8%
Deferred Tax Assets, Valuation Allowance 26.8M USD +7.66%
Deferred Tax Assets, Gross 26.9M USD +7.93%
Operating Lease, Liability 224K USD -31.9%
Depreciation 2K USD -66.7%
Payments to Acquire Property, Plant, and Equipment 9K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.51M USD +20.2%
Lessee, Operating Lease, Liability, to be Paid 256K USD -35.5%
Property, Plant and Equipment, Gross 1.49M USD 0%
Operating Lease, Liability, Current 108K USD +2.86%
Lessee, Operating Lease, Liability, to be Paid, Year Two 90K USD -32.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 133K USD +3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32K USD -52.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 90K USD
Deferred Tax Assets, Operating Loss Carryforwards 20.1K USD +6.7%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 145K USD -20%
Additional Paid in Capital 106M USD +4.13%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 80K USD +515%
Share-based Payment Arrangement, Expense 562K USD +5.05%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%